Results: 1-25 | 26-50 | 51-54
Results: 1-25/54

Authors: Pitt, B
Citation: B. Pitt, The role of ACE-inhibitors in patients with coronary artery disease, CARDIO DRUG, 15(2), 2001, pp. 103-105

Authors: Pitt, B Williams, G Remme, W Martinez, F Lopez-Sendon, J Zannad, F Neaton, J Roniker, B Hurley, S Burns, D Bittman, R Kleiman, J
Citation: B. Pitt et al., The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction, CARDIO DRUG, 15(1), 2001, pp. 79-87

Authors: Furberg, CD Pitt, B
Citation: Cd. Furberg et B. Pitt, Are all angiotensin-converting enzyme inhibitors interchangeable?, J AM COL C, 37(5), 2001, pp. 1456-1460

Authors: Pitt, B Byington, RP Furberg, CD Miller, ME Riley, W Hunninghake, DB Mancini, GBJ
Citation: B. Pitt et al., Does amlodipine increase cancer incidence? Response, CIRCULATION, 104(2), 2001, pp. E5-E5

Authors: Pitt, B Byington, RP Furberg, CD Hunninghake, DB Mancini, GBJ Miller, ME Riley, W
Citation: B. Pitt et al., Confusing press releases and the PREVENT study - Response, CIRCULATION, 104(18), 2001, pp. E95-E95

Authors: Rajagopalan, S Brook, R Rubenfire, M Pitt, E Young, E Pitt, B
Citation: S. Rajagopalan et al., Abnormal bronchial artery flow-mediated vasodilation in young adults with major depression, AM J CARD, 88(2), 2001, pp. 196

Authors: Pitt, B
Citation: B. Pitt, Quinapril Ischemic Event Trial - Reply, AM J CARD, 88(11), 2001, pp. 1348-1348

Authors: Pitt, B O'Neill, B Feldman, R Ferrari, R Schwartz, L Mudra, H Bass, T Pepine, C Texter, M Haber, H Uprichard, A Cashin-Hemphill, L Lees, RS
Citation: B. Pitt et al., The QUinapril Ischemic Event Trial (OUIET): Evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function, AM J CARD, 87(9), 2001, pp. 1058-1063

Authors: Domanski, MJ Sutton-Tyrrell, K Mitchell, GF Faxon, DP Pitt, B Sopko, G
Citation: Mj. Domanski et al., Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization (The BalloonAngioplasty Revascularization Investigation [BARI]), AM J CARD, 87(6), 2001, pp. 675-679

Authors: Pitt, B
Citation: B. Pitt, How can we define heart failure: a new paradigm treatment - Proceedings from the 8th International Congress on Cardiovascular Pharmacotherapy and an Official Satellite Symposium, Amsterdam, The Netherlands, 28 March 1999 - Foreword, EUR H J SUP, 2(A), 2000, pp. A1-A1

Authors: Pitt, B
Citation: B. Pitt, Role of aldosterone receptor blockade in patients with severe heart failure due to systolic left ventricular dysfunction, EUR H J SUP, 2(A), 2000, pp. A25-A28

Authors: Butler, R Oyewole, D Pitt, B
Citation: R. Butler et al., What is the relationship between general practitioners' community referrals, and hospital referrals to an old age psychiatric service?, AGING MENT, 4(1), 2000, pp. 79-81

Authors: Nicklas, JM Cohn, JN Pitt, B
Citation: Jm. Nicklas et al., What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?, J CARD FAIL, 6(2), 2000, pp. 165-168

Authors: Boota, A Johnson, B Lee, KL Blaskovich, MA Liu, SX Kagan, VE Hamilton, A Pitt, B Sebti, SM Davies, P
Citation: A. Boota et al., Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle, AM J P-LUNG, 278(2), 2000, pp. L329-L334

Authors: Cowley, AJ Wiens, BL Segal, R Rich, MW Santanello, NC Dasbach, EJ Pitt, B
Citation: Aj. Cowley et al., Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy, QUAL LIFE R, 9(4), 2000, pp. 377-384

Authors: Adams, KF Baughman, KL Dec, WG Elkayam, U Forker, AD Gheorghiade, M Hermann, D Konstam, MA Liu, P Massie, BM Patterson, JH Silver, MA Stevenson, LW Feldman, AM Cohn, JN Francis, GS Greenberg, B Konstam, MA Leier, C Lorell, BH Packer, M Pitt, B Silver, MA Sonnenblick, E Strobeck, J Walsh, R Yusuf, S
Citation: Kf. Adams et al., HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches, PHARMACOTHE, 20(5), 2000, pp. 495-522

Authors: Pitt, B
Citation: B. Pitt, The anti-ischemic potential of angiotensin-converting enzyme inhibition: Insights hom the heart outcomes prevention evaluation trial, CLIN CARD, 23(7), 2000, pp. IV9-IV14

Authors: Pitt, B Nicklas, JM
Citation: B. Pitt et Jm. Nicklas, Specialized heart failure centers - A success or an indicator of the failure of our health care delivery system, CLIN CARD, 23(12), 2000, pp. 881-882

Authors: Neal, B MacMahon, S Chapman, N Cutler, J Fagard, R Neal, B Whelton, P Yusuf, S Agodoa, L Baigent, C Black, H Boissel, JP Brenner, B Brown, M Bulpitt, C Byington, R Chalmers, J Collins, R Dahlof, B Davis, B Estacio, R Fox, K Hansson, L Holman, R Hunsicker, L Kostis, J Kuramoto, K Kusek, J Lees, R Lewis, E Lindholm, LH Liu, L Lubsen, J Malacco, E Mancia, G Martin, I Pepine, C Pfeffer, M Pitt, B Poole-Wilson, P Remuzzi, G Rodgers, A Ruggenenti, P Schrier, R Sever, P Sleight, P Staessen, J Teo, K Turner, R Wing, L Zanchetti, A Algert, C Woodward, M
Citation: B. Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials, LANCET, 356(9246), 2000, pp. 1955-1964

Authors: Pitt, B Poole-Wilson, P
Citation: B. Pitt et P. Poole-wilson, Comparison of losartan and captopril in ELITE II - Reply, LANCET, 356(9232), 2000, pp. 852-853

Authors: Pitt, B Poole-Wilson, PA Segal, R Martinez, FA Dickstein, K Camm, AJ Konstam, MA Riegger, G Klinger, GH Neaton, J Sharma, D Thiyagarajan, B
Citation: B. Pitt et al., Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II, LANCET, 355(9215), 2000, pp. 1582-1587

Authors: Krumholz, HM Brass, LM Every, NR Spertus, JA Bazzarre, T Cohen, DJ Hlatky, MA Peterson, ED Radford, MJ Weintraub, WS Every, NR Cannon, CP Ellerbeck, EF McNeil, BJ Peterson, ED Radford, MJ Ryan, TJ Smith, SC Spertus, JA Krumholz, HM Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B Spertus, JA Spertus, JA DeLong, ER Eagle, RA Normand, SL Mark, DB McAllister, BD Thomas, JW Weintraub, WS Brass, LM Duncan, PW Goldstein, LB Gorelick, PB Hinchey, JA Matchar, DB Nilasena, D Wennberg, D Williams, LS Wolf, PA
Citation: Hm. Krumholz et al., Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of healthcare quality in cardiovascular disease and stroke, STROKE, 31(4), 2000, pp. 1002-1012

Authors: Pitt, B Perez, A
Citation: B. Pitt et A. Perez, Spironolactone in patients with heart failure - Reply, N ENG J MED, 342(2), 2000, pp. 133-134

Authors: Zannad, F Alla, F Dousset, B Perez, A Pitt, B
Citation: F. Zannad et al., Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES), CIRCULATION, 102(22), 2000, pp. 2700-2706

Authors: Pitt, B Byington, RP Furberg, CD Hunninghake, DB Mancini, GBJ Miller, ME Riley, W
Citation: B. Pitt et al., Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events, CIRCULATION, 102(13), 2000, pp. 1503-1510
Risultati: 1-25 | 26-50 | 51-54